VANESSA BOSTWICK: Open Payments
NPI 1609346147 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 17 payments from 11 companies in 2025. Trend: 2023 $504 · 2024 $586 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| Kite Pharma, Inc. | 3 | $211 |
| Janssen Biotech, Inc. | 2 | $134 |
| Incyte Corporation | 2 | $45 |
| Genentech USA, Inc. | 2 | $42 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| BeOne Medicines USA, Inc. | 1 | $26 |
| Alexion Pharmaceuticals, Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $25 |
| Cycle Pharmaceuticals Inc | 1 | $25 |
| Tempus AI, Inc | 1 | $25 |
Products named: Yescarta, RYBREVANT, Venclexta, PREVYMIS, NIKTIMVO, BRUKINSA, ULTOMIRIS, Phyrago.
Industry payments across NC — which companies pay providers there.
